Pharmamarketeer

University of Oxford and Oracle Cloud System helping researchers identify COVID-19 variants faster

University of Oxford and Oracle Cloud System helping researchers identify COVID-19 variants faster

The fast spread of the highly infectious Delta variant underscores the need for faster identification of COVID-19 mutations. Uniting governments and medical communities in this challenge, the University of Oxford and Oracle’s Global Pathogen Analysis System (GPAS) is now being used by organizations on nearly every continent. Institutions using the platform include: the University of Montreal Hospital Centre Research Centre, the Institute of Public Health Research of Chile, the Oxford University Clinical Research Unit in Vietnam, the Institute of Clinical Pathology and Medical Research – New South Wales Pathology, and Oxford Nanopore Technologies. GPAS is also now part of the Public Health England New Variant Assessment Platform.

University of Oxford and Oracle Cloud System helping researchers identify COVID-19 variants faster (worldpharmanews.com)

Advertentie(s)